Anxiety, Asthma, Stress
Conditions
Keywords
Asthma, Anxiety, Stress, Mindfulness, Buteyko
Brief summary
Administration of a combined program for general (Mindfulness) and respiratory (Buteyko technique) relationship in patients with poorly controlled asthma and anxiety/stress to determine if it provides an improvement in current control and future risk of asthma.
Detailed description
A Mindfulness relaxation program and a Buteyko technique respiratory rehabilitation program will be administered individually and weekly, in 10 sessions (5 face-to-face and 5 telematic sessions afterwards). Patients will be visited 4 times (at inclusion, one month, 6 months and 12 months after the double intervention), where data on asthmatic morbidity, pulmonary function (spirometry), bronchial inflammation (FENO) will be collected and some questionnaires will be administered.
Interventions
OTHERMindfulness and Buteyko techniques
Joint implementation of a general relaxation program and a respiratory rehabilitation program in patients with poorly controlled asthma.
Sponsors
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Intervention model description
A Mindfulness relaxation program and a Buteyko technique respiratory rehabilitation program will be administered individually and weekly, in 10 sessions (5 face-to-face and 5 telematic sessions afterwards).
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosis of poorly controlled asthma * In treatment with a combination of ICS/LABA at medium doses * Anxiety and/or functional dyspnea * Attended in the outpatient consultations of the Asthma Unit of the Pneumology and Allergy Service of the Hospital de la Santa Creu i Sant Pau in Barcelona
Exclusion criteria
* Severe asthma exacerbation in the last 30 days * Severe disabling comorbidity * Severe psychiatric illness * Inability to complete questionnaires.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| % patients with changed asthma control | 1 year | Changes in asthma symptoms measured with the asthma control test (minimum 5 as worse value; maximum 25, as the best value) |
| Changes in asthma exacerbation | 1 year | Changes in asthma exacerbation measured by number of hospital admissions and medical treatments received |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pulmonary function | 1 year | Changes in pulmonary function with spirometry (Forced Expiratory Volume in 1 Second and forced vital capacity) |
| Anxiety | 1 year | Improvement of the anxiety level measured with the test hospital anxiety and depression scale (minimum 0 as the best value, maximum 42 as the worst value) |
| Therapeutic adherence of patients to inhalers | 1 year | Changes in therapeutic adherence of patients to inhalers with the Inhaler Adhesion Test |
| Bronchial inflammation | 1 year | Changes in bronchial inflammation with FENO |
| Functional dyspnea | 1 year | Changes in functional dyspnea measured with the test Nijmegen (minimum 0 as the worst value, maximum 64 as the worst value) |
Countries
Spain
Contacts
Primary ContactVicente Plaza Moral, PhD
Outcome results
None listed